# Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis

> **NCT02510937** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 16 (actual)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DRUG:** CC-90001

## Key facts

- **NCT ID:** NCT02510937
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-05
- **Primary completion:** 2017-02-06
- **Final completion:** 2017-02-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510937, "Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02510937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*